Showing 3161-3170 of 5621 results for "".
- Arctic Vision Announces $32 Million in Series A to Expand and Develop Ophthalmology Pipelinehttps://modernod.com/news/arctic-vision-announces-32-million-in-series-a-to-expand-and-develop-ophthalmology-pipeline/2478009/Arctic Vision, a clinical-stage biotechnology company incubated by Nan Fung Life Sciences and Pivotal BioVenture Partners China in 2019, announced its $32 million Series A financing led by Morningside Ventures, together with its existing investors. Arctic Vision focu
- OCT Angiography Demonstrates Retinal Involvement in Amblyopiahttps://modernod.com/news/oct-angiography-demonstrates-retinal-involvement-in-amblyopia/2478003/Optical coherence tomography angiography (OCT-A) could play a role in diagnosing and understanding the pathogenesis of amblyopia, researchers in Hong Kong report, according to a Reuters report. “Our study, utilizing high-reso
- Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-Specific Antibody Therapeutics for Cancer and Retinal Diseaseshttps://modernod.com/news/numab-therapeutics-and-boehringer-ingelheim-enter-into-collaboration-to-develop-multi-specific-antibody-therapeutics-for-cancer-and-retinal-diseases/2478000/Boehringer Ingelheim and Numab Therapeutics announced that they have entered into a research collaboration and worldwide licensing agreement. It will start with two projects aiming at novel therapies for difficult-to-treat lung and gastrointestinal (GI) cancers and patients with geographic
- Retinopathy Risk Increased in T2DM After Cataract Surgeryhttps://modernod.com/news/retinopathy-risk-increased-in-t2dm-after-cataract-surgery/2477965/People with type 2 diabetes are more likely to develop diabetic retinopathy (DR) after cataract surgery, according a new population-based study, according to a Reuters report. Over six years of follow-up, the adjusted risk of retino
- CDC Broadens Guidance on Americans Facing Risk of Severe COVID-19https://modernod.com/news/cdc-broadens-guidance-on-americans-facing-risk-of-severe-covid-19/2477936/The Centers for Disease Control and Prevention on Thursday broadened its warning about who is at risk of developing severe disease from COVID-19 infection, suggesting even younger people who are obese or have other health conditions can become seriously ill if they contract the virus, according t
- AMA Pushes for Federal Intervention to Reform Prior Authorizationhttps://modernod.com/news/ama-pushes-for-federal-intervention-to-reform-prior-authorization/2477934/Docs say health plans have made little progress toward streamlining prior authorization—despite pledging to do so 2 years ago, according to a FierceHealthcare report.
- Sanofi Sees Potential Approval of COVID-19 Vaccine in First Half of 2021https://modernod.com/news/sanofi-sees-potential-approval-of-covid-19-vaccine-in-first-half-of-2021/2477923/Sanofi said Tuesday that it expects potential approval of a COVID-19 vaccine being jointly developed with GlaxoSmithKline in the first half of next year, brought forward from an earlier estimate of the second half of 2021. A phase 1/2 study of the recombinant protein-based vaccine approach, whic
- FAH Demands More Time For Providers to Repay Advance Medicare Payments Due Soonhttps://modernod.com/news/fah-demands-more-time-for-providers-to-repay-advance-medicare-payments-due-soon/2477909/The Federation of American Hospitals is imploring Medicare to give providers more time to repay advanced Medicare loans sent out to help providers facing a financial crisis from COVID-19, according to a FierceHealthcare
- Santen and Orbis International Join Forces to Expand Access to Training for Eye Care Professionals Through Telemedicine Platformhttps://modernod.com/news/santen-and-orbis-international-join-forces-to-expand-access-to-training-for-eye-care-professionals-through-telemedicine-platform/2477910/Santen Pharmaceutical and Orbis International announced a partnership to develop a suite of digital training tools that will continue to help eye care professionals around the world build their skills. Through the 3-year, global partnership, Orbis and Santen will create online courses, live surgi
- AstraZeneca to Supply Europe Up to 400 Million COVID-19 Vaccine Doseshttps://modernod.com/news/astrazeneca-to-supply-europe-up-to-400-million-covid-19-vaccine-doses/2479514/AstraZeneca announced that it has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA) to supply up to 400 million doses of the University of Oxford’s COVID-19 experimental vaccine, with deliveries starting by the end of this year. CEO Pascal Soriot remarked that ̶